Offer - Urjas Oil for just ₹ 1 X
Cipam S 5 Mg Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Depression.
The correct dosage of Cipam S 5 Mg Tablet depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Cipam S 5 Mg Tablet as well, which are listed below. Usually, these side effects of Cipam S 5 Mg Tablet go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Cipam S 5 Mg Tablet is Moderate for pregnant women and Severe for women who are breastfeeding. In addition, Cipam S 5 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Cipam S 5 Mg Tablet related warnings section.
Cipam S 5 Mg Tablet is contraindicated in people with pre-existing medical conditions like Heart Disease, Calcium Deficiency, Potassium Deficiency as it can result in adverse effects. Other conditions have been mentioned below in the Cipam S 5 Mg Tablet contraindications section.
Additionally, Cipam S 5 Mg Tablet may also adversely react with other medicines. Refer to the list below for further details.
In addition to the above precautions for Cipam S 5 Mg Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Cipam S 5 Mg Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Cipam S 5 Mg Tablet safe for pregnant women?
Cipam S may have some side effects during pregnancy. Pregnant women should discontinue the use of Cipam S, and talk to their doctor, if they notice any discomfort.
Is the use of Cipam S 5 Mg Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Cipam S. So it is adviced to consult the doctor before using it.
What is the effect of Cipam S 5 Mg Tablet on the Kidneys?
Cipam S may have mild side effects on the kidneys.
What is the effect of Cipam S 5 Mg Tablet on the Liver?
Cipam S has very mild side effects on the liver.
What is the effect of Cipam S 5 Mg Tablet on the Heart?
Side effects of Cipam S rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Cipam S 5 Mg Tablet unless your doctor advises you to do so -
Is this Cipam S 5 Mg Tablet habit forming or addictive?
Forming a habit of Cipam S 5 Mg Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Cipam S 5 Mg Tablet. So it is best to avoid driving.
Is it safe?
Cipam S 5 Mg Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Cipam S 5 Mg Tablet has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Cipam S 5 Mg Tablet
It is safe to take Cipam S 5 Mg Tablet with food.
Interaction between Alcohol and Cipam S 5 Mg Tablet
Taking Cipam S 5 Mg Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Celexa® (citalopram HBr)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 458,461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 324-326